Antiarrhythmic properties of specific inhibitors of sarcoplasmic reticulum calcium ATPase in the isolated perfused rat heart after coronary artery ligation  by du Toit, Eugene Francois & Opie, Lionel Henry
- 
Antiarrhythmic 
Reticulum Calci 
After Coronary Artery 
EUGENE FRANCOIS D” TOIT, MSc, LIONEL HENRY aPIE, MD. DPHIL, FACC 
&spite many recent advances in the ~rentment of ischemic 
heart disease, sudden cardiac death associated with ventric- 
ulw fibrillation remains a major CPWC of mortality in West- 
cm society (I). Recently, the proposal has been made that 
excess calcium oscillations may play an important role in 
ixhemic ventricular fibrillation (for a review, see Lubbe et 
al. [2)). Oscillatoty release of calcium from intrace&.dar 
aores is a primary event underlying changes in the transient 
inward current that contribwe to arrhythmogenic activity 
(3). 
Hypothetically. such oscillations. if magnified, could play 
an important role in the genesis of ventricular arrhythmias 
during both isehemia and reperfusion. Ryanodtne and caf- 
feine, both acting on the sarcoplasmic reticulum to modulate 
intmcslkdtu calcium fluxes, have antiarrhythmic properties 
(4,s). Ifcalcium oscillations from the arcoplasmic reticulum 
play a major role in the initiation or perpetuation of serious 
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venkicular arrhythmins, then specilic inhibition of the met- 
abolic pump taking up calcium from the cytosol into the 
swcoylasmic reticulum would also be expected to be antiiiT- 
rhythmic. 
lschemic and reperfusion arrhythmias were provoked in 
the irolated mt heart model by coronary arrety ligation scd 
release. Tkapsigargin. which is very specilk sod inhibits 
60-70% of the calcium ATPax pumps in isolated cardiac 
sarcoplasmic raticulum (6-g). was infused into regionally 
ischemic heats. and the incidence of ischemic and repcrfu- 
sion arrhythmias was monitored. In a separate series of 
experiments. a second specific and possibly more potent 
calcium ATWse pump inhibitor, cyclopiazonic acid (9). was 
used. 
Male Long-Evans tats weighing 250-350 g were anesthe- 
tized with diethyl ether and given 200 1U of heptin intrave- 
nously, and the hearts were rapidly excised and arrested by 
a modified Krebs-Hens&it buffer at 4’C (NaHCO, I25 
mmol/liter]. NaCl [I 18 mmollliter]. KH,P04 [I .2 mmollliterl, 
KC1 14.0 mmol&!rr], MgSO, [I.2 mmoliliter], CatI, Il.25 
mmobliter]. glucose [Il.1 mmoliliter], pH 7.4). All animals 
received care in accordance with the “hinciples of labora- 
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tory Animal Care” of the National Society for Medical 
Research and the “Guide for the Care and Use of Labora- 
tory Animds” prepared by the National Academy of Sci- 
ences (NIH Publication oo. 80-23, revised 1978). For this 
study, a total of 345 mts were used lo perform all hemody 
namic, metabolic and arrhythmia measuremenfs. 
The aorta was cannuhued within I min of excision of the 
heart, and retrograde perfusion (Lange&b mode) was 
started at a constant pressure of 100 cm H20. The perfusion 
medium for the irchemic arrhythmia study wa5 modiied to a 
potassium concentration of 4.8 mr:~oUlitcr. For the rep&u- 
sion arrhythmia study, the calcium concentration was 2.5 
mmolJiter (IO). The buffers were gassed with 95% oxygen 
and 5% carbon dioxide and maintained at 3?C. 
The left anterior descending coronary artery was ligated 
using a 3-O Ti-crnn sulure. The coronary flow was reduced 
by a minimum of 25%, and -35% of th+ left ventricle was 
rendered ischemic(ll\. Electrocardiogram (ECG)elecctrodes 
were attached to the aortic cannula and the tcft ventricle, 
and the incidence of ischemic and reperfuaion arrhythmias 
was monitored by means of an ECG tract. Lefl ventricular 
pressure was monitored using I& ventricular Cannulation 
(2% Abocath-T catheter) or an ultrathin *‘Clinglilm” bal- 
loon inserted into the left venrrkle. The cannula or balloon 
was attached to a F23Db Statham pressure iransduccr, and 
the pressure was recorded together with the KG on a chart 
recorder (Lectmmed Multitrace 2). Coronary ffow and hean 
rates were monitored throughour. 
Pmlneol lor khemk arrhythmia study. Hearts were al- 
lowed a I@-min equilibration period before the drug or 
vehicle (DMSO. 0.01-&t%) infusion was initiated and m&n- 
rained for the duration of the experimm. After 5 min of 
treatment, Ihe tefl anterior descendmg coronary ancry was 
Iiited, and the drug infusion rate was adjusted to Ihe new 
(postligation) coronary flow ride. 
In a second series of hearts, hearts were allowed a IO-min 
equilibration period, the coronary artery was ligated, and 
drug or vehicle infusion was initiated 5 min after ligalion. 
The ligation was left in @don for 30 ndn, and rhe coronary 
flow, heart rate, left venrricular pressure and ECG were 
monitored until the end of the 3Qmin ischemic period. 
Pro+xoI for reprrfusion nrrhythnda study. Hearts were 
stabilized for 10 min before the drug or vehicle infusion was 
inhiated. After 5 min of infusion, left anterior descending 
coronary anery ligation was used to induce regional isch- 
emia for 8, 10, IS, 20, 25 and 30 min. Reperfusion was 
achieved by curting the iiiature across a polyvinyl sheath 
that encompassed the coronary artery. Coronary flow, heart 
rate and ECG were again monitored throughout the experi- 
ment and for !he 1st 2 min of reperfusion. 
M&&olie pro&. Hearts were freeze-clamped with Wol- 
lenberg tongs precooled in liquid nitrogen after 15, 20 and 
30 min of &hernia for later tissue high energy phosphate 
determinations. Tissue samples were then freeze-dried for 
IB h in a Christ Alpha I-4 freczedrierand stored in a freezer 
at -70°C until the assays could be performed. Hearts were 
homogenized in 6% perchloric acid, the extracts were cen- 
trifuged, and the supematant was neutralized with Tris- 
KOH-KCI btier to pH 7.0. Adenosine triphasphate (ATF’I 
and phosphocreatine were assayed spectrophotometrically 
at 340 nm io samples 6om ischemic and nonischemic myc- 
cardium. 
Evahmlion of ventriflllnr urhyilu&s. Ventricular rachy. 
cardia was d&ed ZJ !hree or more consecutive, morph+ 
logkally similar, rapid ventricular extrasystoles. Ventricular 
fibrillation was defined as more than six consecutive ventic- 
ular complexes showiag total irre&riry of morphology 
01). 
P&ma&~@ age&s. Thapsigargin was obtained from 
LC Chemical Corporation. The compound was dissolved in 
DMSO, sod the stock was diluted to the appropriate con- 
centration for use. For 10-s mobliter Ihapoigar&. the 6nal 
DMSO conccntmtion (infused into the !EE!) was 0.1%. 
Thapsigargin, 170 nmoUliter. caused a 62% inhibhion of the 
cardiac sarcoplasmic reticulum ATPase pump activity in 
isolated sarcq~lasmk reticulum vesicles (7). Cyclopiazmk 
acid was obtained from Sigma Chemical Co. The compound 
was dissolved in DMSO and dilukd to the appmpriatc 
concentmtion for use. The final DMSO concenlrarian was 
0.01% (v/v) for lo-’ moblirer cyclopiazmdc acid. In initial 
experiments, bo!h compounds were tested to determine their 
potential inotropk (positive Qp negative) properties in the 
isotated working rat heart model. The two doses (10e6 
moYliter thapsigagin and IO-’ m&liter cyclopiazonic acid) 
used for these arrhythmia s~~diis were chosen to have 
rimitar negative inotropic e&Is, both decreasinga0rlic flow 
by -IS% 10 ZU% (unpublished data). 
St&&al QC&XLY. Results are &en as mean values + 
SEM for the am&r of observatiok. in p~nathesca. Prob- 
ability Ip) values were calculated wilh the Student t test. 
When multiple comparison3 were mark. the Bonferrwi 
correction or analysis of variance (ANOVA) lest was made. 
The Fisher exact test was appkd to mss~3 Iiie diierrnce in 
tht incidcoce of venbicular arrhyulmias between gkx3ps 
WI. 
l?.e!Hilts 
hhylbds and hpdgwgb. fschemic vcnbicular OT- 
rhyIhmias. The incidence of ventrkxlar fibrillation in cmk 
trol hearts (Fii. 1) WBF 83%, whereas in the treated hearts ir 
was 0% (p < 0.002). The duration of ventricular fibrillation 
was 389.6 -c 102 s for eontml hearts (n = 12) and 0 s for 
treated hearts (n = 12) @ c 0.09. The duration of ventric- 
ular kxchycardia and the number of ventricular premature 
bea!s were similar for control and treated hearts. 
Thapsigqjn treatment initiated 5 tin after coronary 
artery ligation decreased Ihe incidence of ischcmic vcntric- 
ular fibrillation from 77% (control) (n = 9) to 14% (n = 7) 
@ < 0.05). There was no diierence in the coronary flow 
values or heart rates between the control and the thapsigar- 
gin-treated hearts. 
Figure 1. lschemic arrhylh- 
miss. Horizontal histogmm pre- 
senting the absolute time of the 
duration of ischemic veniricular 
tachyctiia topa bars) OT fibril- 
lation Wd bars) in individual 
Langend& perfused hearts 
during 30 min of ischemia. Con- 
Irol bearts arc iepiisented by 
the top 12 barsand thapsigargin- 
treated Whaps IlO-* moliliterl~ 
by the bottom I2 bars. The ““m- 
ber of ventricular premature 
beats WPW is presented to the 
right of each bar. Note the ma- 
jor antiarrhythmic acrion ol 
thapsigargin. Hat&d bars = 
normal rhythm. 
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Postischemic levels of All’ and phosphocreatine were 
measured in the ischcmic and nonischemic LOILCS. Tissue 
ATP levels in the ischemic zone were lower than those from 
the nonischemic zone in all hearts except the thapsigargin- 
treated hearts after 15 asd 20 min of ischemia. Adenosine 
tri&osnhatc kvels were 2.40 f 0.14 umoUe in the ischemic 
tissue &d 2.83 2 0.15 &moVg in the~nonis~hemic tissue of 
thapsigargitt-treated hearts after I5 min of ischemia and 2.30 
+ 0. IIJ and 2.78 2 0.30 gmok!g. respectively, after 20 min of 
ischemia. The absence of a tissue ~dient for ATP coincided 
with a decrease in the incidence of roperfusion arrhylhmias 
at 15 and 20 min of qerfusion in the thapsigargin-trezaled 
WttPS. 
&Dlrfusion ventric& orrhvthmias. There was a direct 
con&i& between the incidertce of reperfusion aahyth- 
miss and the ischemic time up to -20 min. The incidence of 
reperfusion ventricular fibrillation increased f?om 29% 10 
67%. 81% aad 9@% in control hearts subjected to 8, IO, I5 or 
20 mitt of ischemia, respecfively. Aiter 25 and 30 min there 
was a decrease to 56% (n = 9) and 42% (n = IL). respec- 
tively. With tbapsigargin (lo‘* molkr) treatment. the 
incidence of rqerfiision ventricular ftbtiliation was reduced 
IO o!%, 0% (p < 0.0s). 25% (p < 0.0021, 46% (p < O.OSL 38% 
and 27%, respectively (Fig. 2). During rope&ion of the IO- 
and IS-min ischemia groups, the incidence of reperfusion 
ventricular tacbycardia was reduced from 83% to 0% (p i 
0.002) and from 87% to 45% (p < 0.05), respectively (Table 
I). 
Thcscdifferences in the inc:dence of reperfusion arrhyth- 
mias occurred without any significant dierettce between the 
heart rate or coronary flow of the treated and fhe control 
hearts (data not shown). 
ArrltyUtmk attd Fydopiaznrtic acid. lschemic ventricular 
urrhyrhmius. l’ix incidence ofventricular Rbrillation in con- 
trol hear& was 83% (Fig. 3). whereas ihe incidence in the 
ISCHEMIC TIME (min) 
treated hearts was 16% (p < 0.051. The duration of ventric- 
ulnr fibrillation was 101.7 C 7.8 s for control heiuts (n = 6) 
and I?0 s for treated hearts (only one treated heart dcvel- 
oped uonukular fibrillation). The time in ventricutar tachy- 
cardia wan 59.5 + 84.6 s (n = 6) For control hearts and 
47.6 f 31.7 s (n = 6) ID < 0.05) for cvclooiazonic-acid- ._ 
treated hearts. Only one treated heart devkop’ed ventricular 
fibrillation, but five control beans fibrillated. 
Treatment by cyclopiazottic acid initiated 5 min after 
coronary artery ligation decreased tihc incidence of iscbemic 
ventricular fibrillation from 77% (control hearts) (n = 9) to 
0% (n = 8) (p i 0.05). lschemic values forcorooary flow and 
heart rate were unchanged ty cyc’3piazonic acid treatment. 
&z&ion vvmricrrlar arrhyrhmios. The incidence of 
repelfusion ventricular fibrillation increased from Sk% to 
Nyrr 2. RcperCusion vedricutar fibrillation WF). Hisrogmm pre- 
sendng the percent incidence of reperfusion ventricular fibrillation 
in conlrol (r&d hers) and thapsigargin-treated (Thaps WI‘” moU 
liter]. hatched harr) LangendodpeFfused hearts&r 8, 10. IS. 20. 
25 and 30 min of regional ischemk. For additional iaformation. see 
Table t. *p < 0.05 versus conuol hearts. ‘*p 4 O.MIZ ~?rsus control 
hearts. 
83% to 160% in control hearts subjected to 10, 15 3: 20 mitt 
of ischemia. At 25 and 30 mitt there was a decrease in the 
incidence of ventricular fibrillation to 71% and 62%. respec- 
tively. With cyclopifuonic acid (lo-’ moliliter) treatment the 
ittctdence of repafusian ventricular fibrillation WBS reduced 
to 33%, 40%, 14% (p < 0.05). 4.4% wd 50%, respectively 
(Fig. 4). These ditferencer in the incidence of ventricular 
fibrillation occurred without any diiexences between lhe 
heart rate or coronary Row of the treated and the control 
hearts. 
The number of ventricular premature beats was consir- 
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f&we 4. Repcrfusion ventricular fibrillation 0. The prcent 
incidence of repxfwion vmtriculu fib&&a in control (sdld baa) 
and cyclopiazonic acid-treated (CPA [IO-’ moblitcrl, htdaed bus) 
LangendwUbearts subject to !A IS. 20.25 and 30 min of hbemia. 
For additional information. KC Table 1. *p < 0.05 wnus cocdml 
hearts. 
tently higher in the cyclopi~onic-aci6treated heatts than in 
the control hearts (Table 2). 
M-h&iDIldU& cIlmMryut.?ryllptia. COP 
onq artery ligation dew&d the &pressure product of 
all hearts by f&X Rate-tresrure twoduct values of the 
drug-treatedkeatts incre&d over tk next 2 min and were 
14,508 * 675 (tbapsigargan) (n = 7) (p C 0.05) and 14.636 f 
1,365 (cyclopiazonic acid) (n = 8) @ < 0.05) compared with 
10,859 k 663 (n = 9) for control hearts (Fig. 5). 
The data obtained suppott the hypothesis that cxcesd 
inlemal calcium ion oscikitionr play an impottanl role in the 
genesis of ischemic and reperfusion ventricular 6btiUation. 
The use of two speailic inhibitors (6.9) of uptakx of calcium 
6 
to 
ions into the sarcoplasmic reticulum decreased the iocidence 
of spontaoeour ischemic and reperfusion ventricular ar- 
lbytbt&S. 
Cytadk~tuo,tbe~retkuIomaodsrrhyth- 
I&S. Although tbc exact mechanisms responsible for the 
iritiatiw of ischemic and repafusion arrhythmias are poorly 
understood, then is good evidence that excew cytosolic 
calcium and abnormal itttmce1htl.w calcium oscillations may 
play a mk in the genesis of cenain types of ischemic and 
reperfusion rrhythmiar (4X-18). These intncellular cal- 
cium oxiUrdions am thought to be caused hy the uptake and 
releax of cakiim km the sarcoplasmic reticulum. which is 
ovcrloade4l with calcium (3). Direct intracellular calcium 
meastuweents how that during electrica!ly induced ventric- 
ular tibrillation. intracellular calcium levels are elevated (10, 
and small .!hysiologic intraceUtdar calcium oscillations are 
F&e 5. Rate-prersure pm&t before and during 
coroI!aiy atiery ligation. The rate-preswe products 
for control and dmg.twted hearts arc presented. 
.%tSd bara - rat*Prcss”re product belore coronary 
antry ligation; bmckxl bus = the value 5 mio after 
ligsttoo: Mtcd b&n = tix value 2.5 mill aftc-drug or 
vehicle treatment was initiated. lp < 0.05 vmus 
contml beam. 
augmented by the transition to ventrtwlar fibrillation (5). 
Ryanodine. a compound that acts on the calcium release 
channel of the sarcoplasmic reticulum. reduced the inci- 
dence ofventricular arrhythmias and blocked the augmented 
calcium oscillations associated with ventricular fibrillation 
(4.5). 
lscbemic time and re too prrhylhmias. The inci- 
dence of reperfusion arrhythmias is related to the duration 
and the cewity of iscbsmia (19). The comoounds tested 
were used at a S.&S of rep&&on times to c&inn that the 
antiarrhpthmic pmpaties of these inhibitors were not 
caused by an anti-inchemic action.. These compounds did not 
merely move the bell-shaped cwve to the right, !hus delay- 
ing the vulnerable period, but decreased the incidence of 
arrhythmias in absolute terms. 
Spectticity ol the catopnds te t& Although 0.17 x l@ 
molfliter of thapsigargjn caused 62% inhibition of ATPase 
pump activity in isolated rat cardiac muscle sarcoplesmic 
reticulum (7). there may be species tiietences in the effect 
of the comwund. A concentration of 2 x IO-’ mo!Jiter of 
thapsigargin totally inhibited ATPdse pump activity in iso- 
lated guinea pig sarcoplasmic reticulum vesicles (Zoi. and 
rubnanomolar concentrations caused AT&e pump inhibi- 
tion in sarcoplasmic reticulum isolated from rabbit skeletal 
muscle (8). There are thapsigargin-insensitive ATPase 
pumps in certain types of tissue (7,21.22). The fact that 
thnpsigargin is a very weak negative inotmpe and does not 
cause cardiac mechanical failure in our model when infused 
in relatively high (IO“ mollliter) concentrations may further 
support (his idea. 
Sludy limitations. Although these compounds have anti- 
arhythmic properties, they are both negatively inotmpic 
agents when used in the working heart model (unpublished 
data). Our model for this study was an isovolumic Langen- 
dortf preparation, oat perfonoing external mechanical work 
in the conventional sense. Under such conditions, cyclopi- 
azonic acid is a negative b&rope but not anegative inotmpe 
(23). Our mechanical data in the LangendorE model con- 
firm reports showing that sarcoplasmic reticulum calcium 
ATPase pump inhibition with cyclopiamnic acid in various 
models had only a slight negative effect on contractile 
variables in the rat (23) and rabbit papillary (24) aad neoaatal 
ventricular muscle 0.5) preparation. This negative lusitropic 
effect was only ap~areat in models using is&etric co&c- 
tion as a measure of function (23). Hence, the improved 
mechanical function in response to both agents found in our 
studies on the coronary ligated heart cannot be extrapolated 
to other, awre physiologic models. 
Data concerning the inotmpic artion of thapsigargia in 
cardiac tissue are at present scarce and conb-adiclory. Our 
data (not presented) show that thapsigargin is a weak naga- 
tive inot&e in the working heart model hut DOI in ihe 
Langendoti model, which is in accord with findings in 
isolated guinea pig myocytes (20). These data are contra- 
dicted by the finding that thapsigargin almast abolishes cell 
shortening in isolated rat ventricular myocyler (6) at virtu- 
ally the r&e concenudtian. 
Our study and those of others cannot fully exclude other 
sites of action for the two compounds studied. Nondhckss, 
these compounds appear lo be valuable twls to aid the study 
of intracellular calcium fluxes in cardiac tissue. However, 
extensive additional clinically applicable investigations 
would be needed before aw aoolication to oatients would be 
possible. 
. . . 
coadusions. The inhibition of sarcoplaamic reticulum 
calcium ATPase aanm activitv bv cvclooiazonic acid or 
qsigargin decreased the ia&& oi isc’hemic and reper- 
fusion arrhythmias. These effects supporl the hypothesis 
that intracellular calcium oscillations mediated by the saw+ 
plasmk reticulum may be responsib!e for wme ischemic and 
reperfusion venbicular arrhythmias. 
